Study Title

68Ga-P16-093 PET/CT Imaging in Primary and Recurrent Breast Cancer Patients

Study Details

Description:

PSMA is highly expressed on the cell surface of the microvasculature of several solid tumors, including breast cancer. This makes it a potentially imaging target for the detection and grading of breast cancer. This pilot study was designed to evaluate the diagnostic performance of 68Ga-P16-093, a novel radiopharmaceutical targeting PSMA, which was compared with 18F-FDG in the same group of breast cancer patients.

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468